The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the underlying metabolic issues that contribute to the disease, said Sanyal, who is the lead author on the new paper and is also a professor of medicine at the VCU School of Medicine
A concrete example that clarifies this boundary is gastrin: multiple adequately powered human trials demonstrated that gastrin-based therapies failed to preserve beta-cell function in type 2 diabetes, and development was largely discontinued by approximately 2010
Now-that food is everywhere, those same survival instincts work against us
These drugs mimic the hormone glucagon-like peptide-1, which helps regulate blood sugar, slow stomach emptying, and reduce appetite
Many patients tolerate these medications well, especially when doses are increased slowly
Learn how these two treatments work, the potential benefits of combining them, and what to ask your provider